For a fun and controversial example, one could look at the RNA vaccines for COVID. Those had some properties that separated them from traditional vaccines such that people relying on the class of "vaccine" might have felt misled. As such, you would have expected government regulation to inform the consumer on the difference to expect in that scenario (which the government did).